Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cheryle Gurk-Turner

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Proceedings (Baylor University. Medical Center)|November 10, 2005
Angiotensin II receptor blockersAmy Barreras, Cheryle Gurk-Turner
Proceedings (Baylor University. Medical Center)|December 8, 2005
Darbepoetin alfa (Aranesp)John Powell, Cheryle Gurk-Turner
Proceedings (Baylor University. Medical Center)|December 8, 2005
Caspofungin: the first agent available in the echinocandin class of antifungalsJoseph Rybowicz, Cheryle Gurk-Turner
Proceedings (Baylor University. Medical Center)|November 10, 2005
Ezetimibe (Zetia): a new type of lipid-lowering agentJigna Patel, Valerie Sheehan, Cheryle Gurk-Turner
Transplantation|September 19, 2012
A comprehensive review of everolimus clinical reports: a new mammalian target of rapamycin inhibitorCheryle Gurk-Turner, Wana Manitpisitkul, Matthew Cooper
Transplantation|May 24, 2008
Thymoglobulin dose optimization for induction therapy in high risk kidney transplant recipientsCheryle Gurk-Turner, Richa Airee, Benjamin Philosophe, et al.
Clinical Transplantation|July 15, 2009
The impact of reduced immunosuppression on graft outcomes in elderly renal transplant recipientsMelissa Badowski, Cheryle Gurk-Turner, Charles Cangro, et al.
Clinical Transplants|June 8, 2010
Rescue therapy for early antibody mediated rejection with a proteasome inhibitor: a case reportWana Manitpisitkul, Nikita Wilson, Matthew Cooper, et al.
Surgical Technology International|January 10, 2018
The Addition of Diclofenac to a Multimodal Pain Control Regimen Decreases Postoperative Pain and Opioid ConsumptionNicole E George, Cheryle Gurk-Turner, Jennifer I Etcheson, et al.
Cureus|April 22, 2020
Diclofenac Versus Ketorolac for Pain Control After Primary Total Joint Arthroplasty: A Comparative AnalysisNicole E George, Cheryle Gurk-Turner, Nequesha S Mohamed, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Proceedings (Baylor University. Medical Center)|November 10, 2005
Angiotensin II receptor blockersAmy Barreras, Cheryle Gurk-Turner
Proceedings (Baylor University. Medical Center)|December 8, 2005
Darbepoetin alfa (Aranesp)John Powell, Cheryle Gurk-Turner
Proceedings (Baylor University. Medical Center)|December 8, 2005
Caspofungin: the first agent available in the echinocandin class of antifungalsJoseph Rybowicz, Cheryle Gurk-Turner
Proceedings (Baylor University. Medical Center)|November 10, 2005
Ezetimibe (Zetia): a new type of lipid-lowering agentJigna Patel, Valerie Sheehan, Cheryle Gurk-Turner
Transplantation|September 19, 2012
A comprehensive review of everolimus clinical reports: a new mammalian target of rapamycin inhibitorCheryle Gurk-Turner, Wana Manitpisitkul, Matthew Cooper
Transplantation|May 24, 2008
Thymoglobulin dose optimization for induction therapy in high risk kidney transplant recipientsCheryle Gurk-Turner, Richa Airee, Benjamin Philosophe, et al.
Clinical Transplantation|July 15, 2009
The impact of reduced immunosuppression on graft outcomes in elderly renal transplant recipientsMelissa Badowski, Cheryle Gurk-Turner, Charles Cangro, et al.
Clinical Transplants|June 8, 2010
Rescue therapy for early antibody mediated rejection with a proteasome inhibitor: a case reportWana Manitpisitkul, Nikita Wilson, Matthew Cooper, et al.
Surgical Technology International|January 10, 2018
The Addition of Diclofenac to a Multimodal Pain Control Regimen Decreases Postoperative Pain and Opioid ConsumptionNicole E George, Cheryle Gurk-Turner, Jennifer I Etcheson, et al.
Cureus|April 22, 2020
Diclofenac Versus Ketorolac for Pain Control After Primary Total Joint Arthroplasty: A Comparative AnalysisNicole E George, Cheryle Gurk-Turner, Nequesha S Mohamed, et al.
Pageof 2